Kendle International Invites You To Attend Its Third Quarter 2005 Earnings Webcast And Conference Call

CINCINNATI, Oct. 6 /PRNewswire-FirstCall/ -- Kendle will conduct a telephone conference call and simultaneous Webcast on Oct. 27 at 8:30 a.m. Eastern Time to discuss its financial results for the Third Quarter 2005. A question and answer session will follow.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO)

Webcast Instructions

To access the live Webcast, go to http://www.kendle.com or http://phx.corporate-ir.net/playerlink.zhtml?c=88712&s=wm&e=1142508. Instructions for accessing the Webcast are provided at both sites. The Webcast will be archived at http://www.kendle.com (click on "Investors") shortly after the call for on-demand replay through 5 p.m. Eastern Time on Nov. 25. Please note that Webcast participants will not be able to ask questions.

System requirements for the Webcast include Windows Media Player software and at least a 28.8 Kbps connection to the Internet. Media Player is downloadable at no charge from http://www.microsoft.com/windows/windowsmedia/default.aspx.

Conference Call Instructions

To register (RSVP) for the telephone conference call, U.S. and Canadian participants should dial (800) 223-7104. Participants outside North America should dial (706) 645-6519.

To participate in the telephone conference call, interested parties in the United States and Canada should dial (800) 399-0069. Participants outside North America should dial (706) 643-3694. A replay will be available through 5 p.m. Eastern Time on Nov. 25 by dialing (706) 645-9291 and entering conference ID number 3500295.

About Kendle

Kendle International Inc. is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share. With the expertise of our more than 1,800 associates worldwide, Kendle has conducted clinical trials or provided regulatory, pharmacovigilance and validation services in 70 countries. Investor kits are available upon request from Kendle, 1200 Carew Tower, 441 Vine Street, Cincinnati, OH 45202, or from the company's Web site at http://www.kendle.com.

Photo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle International Inc.

CONTACT: Patty Frank, Investors, +1-513-763-1992, or Lori Dorer, Media,+1-513-345-1685, both of Kendle International Inc.

MORE ON THIS TOPIC